- Harrington JT, Sommers SC, Kassirer JP. Atheromatous emboli with progressive renal failure: renal arteriography as a probable inciting factor. Ann Int Med 1968: 68: 152-60.
- Gaines PA, Cumberland DC, Kennedy A, Welsh CL, Moorhead P, Rutley MS. Cholesterol embolization: a lethal complication of vascular catheterisation. Lancet 1988: I (8578): 168-70.
- Drost H, Buis B, Haan D, Hillers JA. Cholesterol embolism as a complication of left heart catheterisation: report of seven cases. Br Heart J 1984: 52: 339-42.
- Ramirez G, O'Niell WM, Lambert R, Bloomer HA. Cholesterol embolization: a complication of angiography. Arch Intern Med 1978: 138: 1430-42.
- Thadhani R, Camargo C, Xavier M, Fang L, Bazari H. Atheroembolic renal failure after invasive procedures: natural history based on 52 histologically proven cases. Medicine 1995: 74: 350-8.
- Weitz Z, Gafter U, Chagnae A, Levi J. Cholesterol emboli in atherosclerotic patients: reports of four cases occurring spontaneously or complicating angioplasty and aortorenal bypass. J Am Gerititr Soc 1987: 35: 357-9.
- Fraser I, IhIe B, Kincaid-Smith P. Renal failure due to cholesterol emboli. Aust N Z J Med 1991: 21: 418-21.
- Florey CM. Arterial occlusions produced by emboli from eroded aortic atheromatous plaques. Am J Pathol 1945: 21: 549-65.
- Moolenaar W, Lamers C. Cholesterol crystal embolization in the Netherlands: a review of 842 cases filed in the National Pathology Information System from 1973 through 1994. Arch Intern Med 1996: 156: 653-7.
- Cross SS. How common is cholesterol embolism? J Clin Pathol 1991: 44: 859-61.
- Lie J. Cholesterol atheromatous embolism: the great masquerader revisited. Pathol Annu 1992: 27 pt 2: 17-50.
- Jones DB, Iannaccone PM. Atheromatous emboli in renal biopsies. Am J Pathol 1975: 78: 261-76.
- Scolari F, Bracchi M, Valzorio B, et al. Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrol Dial Transplant 1996: 11: 1607-12.
- Stratford N, Britten K, Gallagher P. Inflammatory infiltrates in human coronary atherosclerosis. Atherosclerosis 1986: 59: 271-6.
- Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986: 6: 131-8.
- Kealy WF. Atheroemholism. J Clin Pathol 1978: 31: 984-9.
- Hammerschmidt DE, Greenberg CS, Yamada O, Craddock PR, Jacob HS. Cholesterol and atheroma lipids activate complement and stimulate granulocytes. J Lab Clin Med 1981: 98: 68-77.
- Vidt D. Cholesterol emboli: a common cause of renal failure. Ann Rev Med 1997: 48: 375-85.
- Ho SW-C, Thatcher GN, Matz LR. Reversible renal failure due to renal cholesterol embolism. Aust N Z J Med 1982: 12: 531-3.
- Cosio FG, Zager RA, Sharma HM. Atheroembolic renal disease causes hypocomplementaemia. Lancet 1985: 2(8447): 118-21.
- Kasinath BS, Corwin HL, Bidani AK, Korbet SM, Schwartz MM, Lewis EJ. Eosinophilia in the diagnosis of atheroembolic renal disease. Am J Nephrol 1987: 7: 173-7.
- Zhang S, Mohammed Q, Burbidge A, Morland CM, Roche WR. Cell cultures from bronchial subepithelial myofibroblasts enhance eosinophil survival in vitro. Eur Respir J 1996: 9: 1839-48.
- Gabbiani G. The cellular derivation and life span of the myofibroblast. Pathol Res Pract 1996: 192: 708-11.
- Gressner AM. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int 1996: 49 (Suppl 54): S39-45.
- Gressner AM, Polzar B, Lahme B, Mannherz H. Induction of rat parenchyma! cell apoptosis by hepatic myofibroblasts via transforming growth factor ß. Hepatology 1996: 23: 571-81.
- Lee KS, Buck M, Houglum K, Chojkier M. Molecular events during myofibroblast activation: is there specificity? Heptology 1996: 24: 742-3.
- Maxwell PH, Ferguson DJP, Nicholls LG, Johnson MH, Ratcliffe PJ. The interstitial response to renal injury: fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney lnt 1997: 52: 715-24.
- Muchaneta-Kuhara EC, El Nahas AM. Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 1997: 12: 904-15.
- Pedadagos E, Hewitson T, Eraser I, Nicholls K, Becker G. Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy. Am J Kidney Dis 1997: 29: 912-6.
- Shi Y, O'Brien JE, Faird A, Zalewski A. Transforming growth factorß 1 expression and myofibroblast formation during arterial repair. Arterioseler Thromb Vase Biol 1996: 16: 1298-305.
- Sternberg S. Histology for Ptithologists. New York: Raven Press, 1992: Chapter 5, Myofibroblast.
- Greenberg A, Bastacky S, Iqbal A, Borochovitz D, Johnson J. Focal segmentai glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations. Am J Kidney Dis 1997: 29: 334-44.
- Mannesse CK, Blankenstijn PJ, Man In'T Veld AJ, Schalekemp MADH. Renal failure and cholesterol embolization: a report of 4 surviving cases and a review of the literature. Clin Nephrol 1991: 36: 240-5.
- Ben-Chitrit S, Korzets Z, Hershkovitz R, Bernheim J, Schneider M, Bernheim J. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator. Nephrol Dial Transplant 1994: 9: 428-30.
- Keen R, McCarthy W, Shireman P, et al. Surgical management of atheroembolization. J Vase Surg 1995: 21: 773-81.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research